PTPN18 Serves as a Potential Oncogene for Glioblastoma by Enhancing Immune Suppression
Sign Up to like & getrecommendations! Published in 2023 at "Oxidative Medicine and Cellular Longevity"
DOI: 10.1155/2023/2994316
Abstract: Glioblastoma is characterized as one of the deadliest cancers in humans. The survival time is not improved by standard treatment. Although immunotherapy has revolutionized cancer treatment, the current therapy targets for glioblastoma patients are not… read more here.
Keywords: ptpn18 serves; glioblastoma; immune suppression; ptpn18 ... See more keywords